[{"id":"149819dc-f2ee-4b82-83e1-8c607402853f","acronym":"","url":"https://clinicaltrials.gov/study/NCT02909777","created_at":"2021-01-18T14:16:53.862Z","updated_at":"2025-02-25T14:50:16.761Z","phase":"Phase 1","brief_title":"Trial of CUDC-907 in Children and Young Adults with Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma","source_id_and_acronym":"NCT02909777","lead_sponsor":"Dana-Farber Cancer Institute","biomarkers":" MYC • MYCN","pipe":" | ","alterations":" MYCN expression","tags":["MYC • MYCN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYCN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e fimepinostat (CUDC-907)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 26","initiation":"Initiation: 10/01/2016","start_date":" 10/01/2016","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2025-02-13"},{"id":"db508520-4ea9-4c84-8d31-9c56429ac8f4","acronym":"","url":"https://clinicaltrials.gov/study/NCT01798004","created_at":"2021-01-18T07:57:29.532Z","updated_at":"2024-07-02T16:35:15.000Z","phase":"Phase 1","brief_title":"Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","source_id_and_acronym":"NCT01798004","lead_sponsor":"Children's Oncology Group","biomarkers":" MYCN","pipe":" | ","alterations":" MYCN amplification • MYCN expression","tags":["MYCN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYCN amplification • MYCN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • topotecan • melphalan • mesna • busulfan • Neupogen (filgrastim) • cyclophosphamide intravenous"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 150","initiation":"Initiation: 04/08/2013","start_date":" 04/08/2013","primary_txt":" Primary completion: 07/28/2015","primary_completion_date":" 07/28/2015","study_txt":"","study_completion_date":"","last_update_posted":"2024-03-13"},{"id":"365bcd51-2ab8-4615-b16d-85cc815ed781","acronym":"","url":"https://clinicaltrials.gov/study/NCT01505569","created_at":"2021-01-18T06:19:27.289Z","updated_at":"2025-02-25T14:00:01.019Z","phase":"","brief_title":"Auto Transplant for High Risk or Relapsed Solid or CNS Tumors","source_id_and_acronym":"NCT01505569","lead_sponsor":"Masonic Cancer Center, University of Minnesota","biomarkers":" MYCN • CD34","pipe":" | ","alterations":" LDH elevation • MYCN expression","tags":["MYCN • CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LDH elevation • MYCN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • carboplatin • paclitaxel • ifosfamide • etoposide IV • melphalan • mesna • thiotepa • busulfan"],"overall_status":"Completed","enrollment":" Enrollment 44","initiation":"Initiation: 10/20/2011","start_date":" 10/20/2011","primary_txt":" Primary completion: 02/01/2024","primary_completion_date":" 02/01/2024","study_txt":" Completion: 02/01/2024","study_completion_date":" 02/01/2024","last_update_posted":"2024-02-26"},{"id":"229d640d-e215-4e13-b783-8f896525d757","acronym":"","url":"https://clinicaltrials.gov/study/NCT03581240","created_at":"2021-01-18T17:37:06.419Z","updated_at":"2024-07-02T16:35:35.353Z","phase":"","brief_title":"An Intermediate Expanded Use Trial of DFMO","source_id_and_acronym":"NCT03581240","lead_sponsor":"Giselle Sholler","biomarkers":" MYCN","pipe":" | ","alterations":" MYCN amplification • MYCN expression","tags":["MYCN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYCN amplification • MYCN expression"],"overall_status":"Available","enrollment":"","initiation":"","start_date":"","primary_txt":"","primary_completion_date":"","study_txt":"","study_completion_date":"","last_update_posted":"2023-09-28"},{"id":"976662e5-c9f9-45e1-a8a7-ec85c4257402","acronym":"","url":"https://clinicaltrials.gov/study/NCT01387724","created_at":"2021-01-18T05:41:39.859Z","updated_at":"2024-07-02T16:37:31.996Z","phase":"","brief_title":"Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma","source_id_and_acronym":"NCT01387724","lead_sponsor":"Children's Oncology Group","biomarkers":" NTRK2 • MYCN • BDNF","pipe":" | ","alterations":" MYCN amplification • MYCN expression • NTRK expression","tags":["NTRK2 • MYCN • BDNF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYCN amplification • MYCN expression • NTRK expression"],"overall_status":"Completed","enrollment":" Enrollment 300","initiation":"Initiation: 06/01/2011","start_date":" 06/01/2011","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":"","study_completion_date":"","last_update_posted":"2016-05-18"}]